Age-related macular degeneration: Beyond anti-angiogenesis

Molecular Vision

Volumn 20, Issue , 2014, Pages 46-55

  Kent, David L ^a,b  

^a Vision Clinic   (Ireland)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN INHIBITOR; VERTEPORFIN;

ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; CHRONIC INFLAMMATION; DIABETIC RETINOPATHY; HUMAN; HYPOXEMIA; LASER COAGULATION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA SURGERY; SUBRETINAL NEOVASCULARIZATION; THERAPY EFFECT; WOUND HEALING;

ANGIOGENESIS INHIBITORS; CHOROIDAL NEOVASCULARIZATION; HUMANS; MACULAR DEGENERATION;

EID: 84891766084     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (104)

1. Brown DM, Michels M, Kaiser PK, Heier JS, Sy J P, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology 2009; 116:57-65.
2. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364:1897-1908. [PMID: 21526923].
3. Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 2008; 145:239-248. [PMID: 18222192].
4. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355:1419-1431. [PMID: 17 0 21 31 8].
5. Age-related macular degeneration. The Macular Photoco-agulation Study. Am J Ophthalmol 1984; 98:376-377. [PMID: 6540994].
6. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1986; 104:694 -701. [PMID: 2 42 30 61].
7. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1990; 108:816-824. [PMID: 1693 49 6].
8. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109:1220-1231. [PMID: 1718250].
9. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109:1232-1241. [PMID: 1718 2 51].
10. Photodynamic therapy of subfoveal choroidal neovasculariza-tion in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photody-namic therapy (TAP) Study Group. Arch Ophthalmol 1999; 117:1329-1345. [PMID: 10532 4 41].
11. Photodynamic therapy of subfoveal choroidal neovasculariza-tion in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report no. 1. Ophthalmology 2001; 108:841-852. [PMID: 1132 0 011].
12. Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC. Verteporfin therapy of subfoveal minimally classic choroidal neovasculariza-tion in age-related macular degeneration: 2-year results of a randomized clinical trial. Arch Ophthalmol 2005; 123:448-457. [PMID: 158 2 4 216].
13. Laser photocoagulation for juxtafoveal choroidal neovascu-larization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group Arch Ophthalmol 1994; 112:500-509. see comments[PMID: 7512336].
14. Persistent and recurrent neovascularization after laser photo-coagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol 1994; 112:489-499. [PMID: 7512335].
15. MacLean AL, Maumenee AE. Hemangioma of the choroid. Am J Ophthalmol 1960; 50:3-11. [PMID: 14419565].
16. Novotny HR, Alvis DL. A method of photographing fluores-cence in circulating blood in the human retina. Circulation 1961; 24:82-86. [PMID: 13729802].
17. Maiman T. Stimulated optical radiation in ruby. Nature 1960; 187:493-494.
18. Meyer-Schwickerath GR. The history of photocoagulation. Aust N Z J Ophthalmol 1989; 17:427-434. [PMID: 2696498].
19. Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am J Ophthalmol 1976; 81:383-396. [PMID: 944535].
20. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103:1796-1806. [PMID: 2866759].
21. Fine SL. Macular photocoagulation study. Arch Ophthalmol 1980; 98:832. [PMID: 6155116].
22. Chamberlin JA, Bressler NM, Bressler SB, Elman MJ, Murphy RP, Flood TP, Hawkins BS, Maguire MG, Fine SL. The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. The Macular Photo-coagulation Study Group. Ophthalmology 1989; 96:1526-1534. [PMID: 2479899].
23. Cruess AF, Berger A, Colleaux K, Greve M, Harvey P, Kertes PJ, Sheidow T, Tourville E, Williams G, Wong D. Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration. Can J Ophthalmol 2012; 47:227-235. [PMID: 22687297].
24. Kent D, Sheridan C. Choroidal neovascularization: a wound healing perspective. Mol Vis 2003; 9:747-755. [PMID: 14 7 35 0 62].
25. Sheridan CM, Pate S, Hiscott P, Wong D, Pattwell DM, Kent D. Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol 2009; 247:1361-1367. [PMID: 19590888].
26. Sheridan CM, Rice D, Hiscott PS, Wong D, Kent DL. The presence of AC133-positive cells suggests a possible role of endothelial progenitor cells in the formation of choroidal neovascularization. Invest Ophthalmol Vis Sci 2006; 47:1642-1645. [PMID: 16565404].
27. Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, Cohen C, Elner VM, Elner SG, Sternberg P Jr. Macro-phage and retinal pigment epithelium expression of angio-genic cytokines in choroidal neovascularization. Mol Vis 2002; 8:119-126. [PMID: 119 79 2 37].
28. Grossniklaus HE, Martinez JA, Brown VB, Lambert HM, Sternberg P Jr, Capone A Jr, Aaberg TM, Lopez PF. Immu-nohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 1992; 114:464-472. [PMID: 1415 458].
29. Hunt TK. Basic principles of wound healing. J Trauma 1990; 30:S122-S128. [PMID: 2254971].
30. Kirsner RS, Eaglstein WH. The wound healing process. Dermatol Clin 1993; 11:629-640. [PMID: 8222347].
31. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341:738-746. [PMID: 10 4714 61].
32. Lopez PF, Green WR. Peripapillary subretinal neovasculariza-tion. A review. Retina 1992; 12:147-171. [PMID: 1439246].
33. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308:421-424. [PMID: 15761121].
34. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102:7227-7232. [PMID: 15870199].
35. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308:419-421. [PMID: 15761120].
36. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MD, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308:385-389. [PMID: 1576112 2].
37. Forrester JV. Bowman lecture on the role of inflammation in degenerative disease of the eye. Eye (Lond) 2013; 27:340-352. [PMID: 23288138].
38. Demidova-Rice TN, Hamblin MR, Herman IM. Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care. Adv Skin Wound Care 2012; 25:304-314. [PMID: 2 2713781].
39. Xu H, Chen M, Forrester JV. Para-inflammation in the aging retina. Prog Retin Eye Res 2009; 28:348-368. [PMID: 19560552].
40. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 2010; 29:95-112. [PMID: 19961953].
41. Nasir MA, Sugino I, Zarbin MA. Decreased choriocapillaris perfusion following surgical excision of choroidal neovas-cular membranes in age-related macular degeneration. Br J Ophthalmol 1997; 81:481-489. [PMID: 9274 413].
42. Sarks JP, Sarks SH, Killingsworth MC. Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity. Eye (Lond) 1997; 11:515-522. [PMID: 9425 418].
43. McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 2009; 50:4982-4991. [PMID: 19357355].
44. Mullins RF, Johnson MN, Faidley EA, Skeie JM, Huang J. Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52:1606-1612. [PMID: 21398287].
45. Bilton RL, Booker GW. The subtle side to hypoxia induc-ible factor (HIFalpha) regulation. Eur J Biochem 2003; 270:791-798. [PMID: 12603312].
46. Lee BL, Kim WH, Jung J, Cho SJ, Park JW, Kim J, Chung HY, Chang M.S. Nam SY. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angio-genesis in human gastric cancer. Carcinogenesis 2008; 29:44-51. [PMID: 1798 4117].
47. Ndubuizu OI, Tsipis CP, Li A, LaManna JC. Hypoxia-inducible factor-1 (HIF-1)-independent microvascular angiogenesis in the aged rat brain. Brain Res 2010; 1366:101-109. [PMID: 20875806].
48. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004; 12 2: 598-614. [PMID: 15078679].
49. Green WR, Enger C. Age-related macular degeneration histo-pathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993; 100:1519-1535. [PMID: 7692366].
50. Acosta JB, del Barco DG, Vera DC, Savigne W, Lopez-Saura P, Guillen Nieto G, Schultz GS. The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J 2008; 5:530-539. [PMID: 19006574].
51. Gary Sibbald R, Woo KY. The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev 2008; 24:Suppl 1S25-1S30. [PMID: 18 4 42179].
52. Nicolaides AN. Chronic venous disease and the leukocyte-endothelium interaction: from symptoms to ulceration. Angiology 2005; 56:Suppl 1S11-1S19. [PMID: 161932 21].
53. Pradhan L, Cai X, Wu S, Andersen ND, Martin M, Malek J, Guthrie P, Veves A, Logerfo FW. Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. J Surg Res 2011; 167:336-342. [PMID: 20070982].
54. Pradhan L, Nabzdyk C, Andersen ND, LoGerfo FW, Veves A. Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med 2009; 11:e2 [PMID: 19138453].
55. Raffetto JD. Dermal pathology, cellular biology, and inflam-mation in chronic venous disease. Thromb Res 2009; 123:Suppl 4S66-4S71. [PMID: 19303508].
56. Smith PD. Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology 2001; 52:Suppl 1S35-1S42. [PMID: 11510 595].
57. Van Geest RJ, Lesnik-Oberstein SY, Tan HS, Mura M, Gold-schmeding R, Van Noorden CJ, Klaassen I, Schlingemann RO. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol 2012; 96:587-590. [PMID: 22289291].
58. Morgan CM, Schatz H. Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation. Ophthalmology 1989; 96:96-103. [PMID: 2919053].
59. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988; 32:375-413. [PMID: 2457955].
60. Dastgheib K, Bressler SB, Green WR. Clinicopathologic corre-lation of laser lesion expansion after treatment of choroidal neovascularization. Retina 1993; 13:345-352. [PMID: 7509504].
61. Fujii GY, De Juan E Jr, Pieramici DJ, Humayun MS, Phillips S, Reynolds SM, Melia M, Schachat AP. Inferior limited macular translocation for subfoveal choroidal neovascular-ization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. Am J Ophthalmol 2002; 134:69-74. [PMID: 12095810].
62. Green WR. Clinicopathologic studies of treated choroidal neovascular membranes. A review and report of two cases. Retina 1991; 11:328-356. [PMID: 172 0 565].
63. Rosa RH, Thomas MA, Green WR. Clinicopathologic correla-tion of submacular membranectomy with retention of good vision in a patient with age-related macular degeneration. Arch Ophthalmol 1996; 114:480-487. [PMID: 8602790].
64. Okunaka T, Eckhauser ML, Kato H, Bomaminio A, Yama-moto H, Aizawa K, Sarasua MM, Koehler KA. Correlation between photodynamic efficacy of differing porphyrins and membrane partitioning behavior. Lasers Surg Med 1992; 12:98-103. [PMID: 1535406].
65. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976; 36:2326-2329. [PMID: 1277137].
66. Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 2001; 119:198-207. [PMID: 1117 6 9 8 0].
67. Hörster R, Ristau T, Sadda SR, Liakopoulos S. Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2011; 249:645-652. [PMID: 211705 47].
68. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219:983-985. [PMID: 6823562].
69. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-1659. [PMID: 3537791].
70. Grossniklaus HE, Miskala PH, Green WR, Bressler SB, Hawkins BS, Toth C, Wilson DJ, Bressler NM. Histopatho-logic and ultrastructural features of surgically excised subfo-veal choroidal neovascular lesions: submacular surgery trials report no. 7. Arch Ophthalmol 2005; 123:914-921. [PMID: 16009831].
71. Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL. Natural history of choroidal neovasculariza-tion in degenerative myopia. Ophthalmology 1984; 91:1573-1581. [PMID: 6084222].
72. Grossniklaus HE, Green WR. Pathologic findings in patho-logic myopia. Retina 1992; 12:127-133. [PMID: 1439243].
73. Keane PA, Liakopoulos S, Chang KT, Heussen FM, Ongchin SC, Walsh AC, Sadda SR. Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis. Br J Ophthalmol 2008; 92:1081-1085. [PMID: 185869 03].
74. Wood CM, Richardson J. Chorioretinal neovascular membranes complicating contusional eye injuries with indirect choroidal ruptures. Br J Ophthalmol 1990; 74:93-96. [PMID: 169 0 025].
75. Wyszynski RE, Grossniklaus HE, Frank KE. Indirect choroidal rupture secondary to blunt ocular trauma. A review of eight eyes. Retina 1988; 8:237-243. [PMID: 2 4 6 6317].
76. Grossniklaus HE, Hutchinson AK, Capone A Jr, Woolfson J, Lambert HM. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology 1 9 9 4; 101:1099-1111. [PMID: 7516 516].
77. Libby P, Ridker PM, Maseri A. Inflammation and atheroscle-rosis. Circulation 2002; 105:1135-1143. [PMID: 1187 736 8].
78. Augoustides JG, Ramakrishna H. Recent advances in the management of coronary artery disease: highlights from the literature. J Cardiothorac Vasc Anesth 2009; 23:259-265. [PMID: 19324285].
79. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropop-liteal disease. A decision and cost-effectiveness analysis. JAMA 1995; 274:165-171. [PMID: 7596006].
80. Kakisis JD, Avgerinos ED, Antonopoulos CN, Giannako-poulos TG, Moulakakis K, Liapis CD. The European Society for Vascular Surgery guidelines for carotid intervention: an updated independent assessment and literature review. Eur J Vasc Endovasc Surg 2012; 44:238-243. [PMID: 22658616].
81. Kan P, Mokin M, Dumont TM, Snyder KV, Siddiqui AH, Levy EI, Hopkins LN. Cervical carotid artery stenosis: latest update on diagnosis and management. Curr Probl Cardiol 2012; 37:127-169. [PMID: 2 23914 0 7].
82. Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, Bossavy JP, Denis B, Piquet P, Garnier P, Viader F, Touze E, Julia P, Giroud M, Krause D, Hosseini H, Becquemin JP, Hinzelin G, Houdart E, Henon H, Neau J P, Bracard S, Onnient Y, Padovani R, Chatellier G. Endarter-ectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol 2008; 7:885-892. [PMID: 18774745].
83. Green GE, Paul RS, Wallsh E, Tice DA. Coronary artery bypass grafting. Surg Forum 1968; 19:159-161. [PMID: 571859 8].
84. Sasayama S, Fujita M. Recent insights into coronary collat-eral circulation. Circulation 1992; 85:1197-1204. [PMID: 13 71432].
85. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine J P, Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10:858-864. [PMID: 15235597].
86. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721-32. [PMID: 13130303].
87. Ryan SJ. Subretinal neovascularization. Natural history of an experimental model. Arch Ophthalmol 1982; 100:1804-1809. [PMID: 6182868].
88. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, Vinores SA, Basilico C, Campochiaro PA. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998; 153:1641-1646. [PMID: 9 8113 57].
89. Chan-Ling T, Baxter L, Afzal A, Sengupta N, Caballero S, Rosinova E, Grant MB. Hematopoietic stem cells provide repair functions after laser-induced Bruch's membrane rupture model of choroidal neovascularization. Am J Pathol 2006; 168:1031-1044. [PMID: 16507916].
90. Harris JR, Brown GA, Jorgensen M, Kaushal S, Ellis EA, Grant MB, Scott EW. Bone marrow-derived cells home to and regenerate retinal pigment epithelium after injury. Invest Ophthalmol Vis Sci 2006; 47:2108-2113. [PMID: 16639 022].
91. Bitto A, Minutoli L, Galeano MR, Altavilla D, Polito F, Fiumara T, Calo M, Lo Cascio P, Zentilin L, Giacca M, Squadrito F. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression. Clin Sci (Lond) 2008; 114:707-718. [PMID: 18078386].
92. Cianfarani F, Zambruno G, Brogelli L, Sera F, Lacal PM, Pesce M, Capogrossi MC, Failla CM, Napolitano M, Odorisio T. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol 2006; 16 9:1167-1182. [PMID: 17 0 0 3 4 76].
93. Pierce GF, Tarpley JE, Yanagihara D, Mustoe TA, Fox GM, Thomason A. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol 1992; 140:1375-1388. [PMID: 1376557].
94. Green WR, Gass JD. Senile disciform degeneration of the macula. Retinal arterialization of the fibrous plaque demonstrated clinically and histopathologically. Arch Ophthalmol 1971; 86:487-494. [PMID: 5114441].
95. Hartnett ME, Weiter JJ, Garsd A, Jalkh AE. Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 1992; 230:11-19. [PMID: 15 47961].
96. Hartnett ME, Weiter JJ, Staurenghi G, Elsner AE. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 1996; 103:2042-2053. [PMID: 9003338].
97. Kuhn D, Meunier I, Soubrane G, Coscas G. Imaging of chorio-retinal anastomoses in vascularized retinal pigment epithelium detachments. Arch Ophthalmol 1995; 113:1392-1398. [PMID: 7487600].
98. Lafaut BA, Aisenbrey S, Vanden Broecke C, Bartz-Schmidt KU. Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration. Br J Ophthalmol 2000; 84:1269-1274. [PMID: 110 49 9 53].
99. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, Freund KB, Sorenson J, Orlock D, Borodoker N. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21:416-434. [PMID: 116 42 370].
100. Eriksson A, Cao R, Roy J, Tritsaris K, Wahlestedt C, Dissing S, Thyberg J, Cao Y. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation 2003; 107:1532-1538. [PMID: 12654612].
101. van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, Tumas D, Gerlai R, Williams SP, van Lookeren Campagne M, Ferrara N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 1999; 104:1613-1620. [PMID: 10587525].
102. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 9:604-613. [PMID: 12669032].
103. Shyu KG, Chang H, Isner JM. Synergistic effect of angio-poietin-1 and vascular endothelial growth factor on neoan-giogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. Life Sci 2003; 73:563-579. [PMID: 12770612].
104. Yamamoto Y, Matsuura T, Narazaki G, Sugitani M, Tanaka K, Maeda A, Shiota G, Sato K, Yoshida A, Hisatome I. Syner-gistic effects of autologous cell and hepatocyte growth factor gene therapy for neovascularization in a murine model of hindlimb ischemia. Am J Physiol Heart Circ Physiol 2009; 297:H1329-H1336. [PMID: 19666845].